1. "Journal for ImmunoTherapy of Cancer"
Formats
  1. Meeting Abstract (237)
  2. Journal Article (137)
  3. Guidelines (20)
  4. Review (6)
  5. Editorial (2)
  6. Correspondence (1)
Groups
  1. Department of Medicine (346)
  2. Solid Tumor Oncology Division (315)
  3. Melanoma and Immunotherapeutics Service (131)
  4. GSK Faculty (120)
  5. Hematologic Malignancies, Division of (98)
  6. Sloan Kettering Institute Postdocs (85)

More Groups

People
  1. Jedd Wolchok (81)
  2. Taha Merghoub (55)
  3. Michael Postow (34)
  4. Matthew Hellmann (30)
  5. Roberta Zappasodi (24)
  6. Sadna Budhu (22)

More People

Years
  1. 2025 (4)
  2. 2024 (18)
  3. 2023 (21)
  4. 2022 (75)
  5. 2021 (57)
  6. 2020 (58)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (403)
Publishers
  1. Biomed Central Ltd (403)

Results (403)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events
    Journal Article

    Middha, P.; Thummalapalli, R.; Quandt, Z.; Balaratnam, K.; Cardenas, E.; Falcon, C. J.; Princess Margaret Lung Group; Gubens, M. A.; Huntsman, S.; Khan, K.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • Effect of prior and first-line immunotherapy on baseline immune biomarkers and modulation of the tumor microenvironment in response to nivolumab and relatlimab combination therapy in patients with melanoma from RELATIVITY-020
    Journal Article

    Ascierto, P. A.; Tang, H.; Dolfi, S.; Nyakas, M.; Marie Svane, I.; Muñoz-Couselo, E.; Grob, J. J.; Gomez-Roca, C. A.; Chiarion-Sileni, V.; Peltola, K.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: Subgroup analyses from the CIBMTR registry
    Journal Article

    Landsburg, D. J.; Frigault, M. J.; Heim, M.; Foley, S. R.; Hill, B.; Schofield, G.; Jacobson, C. A.; Jaglowski, S.; Locke, F. L.; Ram, R.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • Society for Immunotherapy of Cancer: Updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing
    Review

    Taube, J. M.; Sunshine, J. C.; Angelo, M.; Akturk, G.; Eminizer, M.; Engle, L. L.; Ferreira, C. S.; Gnjatic, S.; Green, B.; Greenbaum, S.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • Clinical benefit with tebentafusp in a patient with GNAQ mutant metastatic blue nevus-associated melanoma
    Journal Article

    Kudelka, M. R.; Richards, A. L.; Friedlander, P.; Wolchok, J. D.; Moy, A. P.; Shoushtari, A. N.
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Phase I study of a recombinant attenuated oncolytic virus, MEDI5395 (NDV-GM-CSF), administered systemically in combination with durvalumab in patients with advanced solid tumors
    Journal Article

    Davar, D.; Carneiro, B. A.; Dy, G. K.; Sheth, S.; Borad, M. J.; Harrington, K. J.; Patel, S. P.; Galanis, E.; Samson, A.; Agrawal, S.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): Expansion cohorts and correlative analyses
    Journal Article

    Seligson, N. D.; Chen, J. L.; Goodrich, A. C.; Van Tine, B. A.; Campbell, J. D.; Richards, A. L.; Antonescu, C. R.; Liebner, D. A.; Milhem, M. M.; Streicher, H.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • First-in-human clinical outcomes with NG-350A, an anti-CD40 expressing tumor-selective vector designed to remodel immunosuppressive tumor microenvironments
    Journal Article

    Naing, A.; Khalil, D.; Rosen, O.; Camidge, D. R.; Lillie, T.; Ji, R. R.; Stacey, A.; Thomas, M.; Rosen, L.
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214
    Journal Article

    Mantia, C. M.; Jegede, O. A.; Plimack, E. R.; Powles, T.; Motzer, R. J.; Tannir, N. M.; Lee, C. H.; Tomita, Y.; Voss, M. H.; Choueiri, T. K.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Open-capsule budesonide for the treatment of immune-related enteritis from checkpoint inhibitors
    Journal Article

    Magahis, P. T.; Corso, T.; Livingstone, P.; Tom, E.; Srivastava, A.; Postow, M.; Faleck, D.
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save